05/06/2023

World Environment Day – #BeatPlasticPollution

On the occasion of the “World Environment Day” – June 5 – focusing this year on the theme:   #BeatPlasticPollution, we are proud to join the global campaign as a socially and environmentally responsible company and as Zdravlje employees highly aware of the importance of our individual and collective contribution to […]
01/06/2023

Dmitriy Sovetkin appointed as Zdravlje Commercial Director

Zdravlje AD is delighted to announce the appointment of Dr. Dmitriy Sovetkin to its leadership team as Commercial Director, effective June 1, 2023. Dr. Sovetkin will report to Group CEO, Kiren Naidoo. Dmitriy brings over 20 years of proven success as an experienced leader within the pharmaceutical industry. He has […]
18/04/2023

Vishal Kumar Gupta appointed as Group Chief Financial Officer (CFO)

Frontier Pharma Limited and Zdravlje AD are pleased to announce that Mr. Vishal Kumar Gupta has joined our leadership team as Group Chief Financial Officer, reporting to Kiren Naidoo (CEO). Vishal joins us from the United Kingdom and brings c. 15 years’ experience in various leadership positions including at Essar […]
10/04/2023

Important promotions in Zdravlje Management Team

It is with great pleasure that we would like to inform about the important promotions in our Zdravlje Management Team. These changes come as we optimize and position Zdravlje as an independent Contract Development and Manufacturing Organization (CDMO) which has the flexibility to respond to market and client needs. We […]
22/02/2023

Dr Milan Popovic, Sales Manager, onboarding the Commercial Business Unit in Zdravlje AD

Zdravlje is pleased to announce that as of 10th February 2023, Dr Milan Popovic has joined our team as a Sales Manager. Milan will lead our Sales team and closely cooperate with Zdravlje Commercial team from our Belgrade Office. Milan graduated as a Doctor of Medicine from the University of […]
18/01/2023

Cape Town-based biotechnology company, Afrigen, appoints new board chair

We are very proud to announce that our Chairman and Board Member, Mr. Levent Selamoglu has been appointed as Chairman of Afrigen Biologics.  Afrigen is a leading biotechnology company based in Cape Town, South Africa.  The company is focused on product development, bulk adjuvant manufacturing and distribution of key biologicals […]
27/12/2022

Zdravlje (Frontier Biopharma) and Adalvo Sign Licensing & Supply Agreement for Central & Eastern Europe

Zdravlje / Frontier Biopharma (“Frontier”) and  Adalvo are pleased to announce their collaboration in several therapeutic areas for the markets of Central and Eastern Europe and the Balkans. Over the next months and years, this collaboration will extend Frontier’s commercial and therapeutic footprint with a basket of more than 30 molecules from Adalvo’s advanced […]
13/12/2022

Zdravlje Leskovac Awarded for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia

We are proud to announce that Zdravlje Leskovac has received the Award for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia. At the Ceremony held on 9 December, the Chamber of Commerce and Industry of Serbia awarded the traditional Annual Awards to the most successful […]
29/09/2022

Zdravlje Leskovac at “Serbia Business Run” in Belgrade

We work, run, enjoy TOGETHER Zdravlje Leskovac participated for the first time on September 29. at the great “Serbia Business Run“ in Belgrade. This manifestation, which aims to promote healthy lifestyles and running as a great way of recreation for the modern working person, is a series of 5 km […]
01/09/2022

Tsvetomir Yordanov joins Zdravlje Leskovac as Group Business Development Director

Zdravlje is pleased to announce that as of 1st September 2022, Mr. Tsvetomir Yordanov has joined our senior management team as Group Business Development Director, directly reporting to Kiren Naidoo (CEO). Tsvetomir graduated in International Business and holds a master’s degree in Public Finance from the UNWE (Economics University), Sofia, Bulgaria. […]